Can a Person With Thyroid Disease Use Weight Loss Injections?

Having thyroid disease does not, by itself, automatically prevent the use of weight loss injections. Some people with controlled hypothyroidism or Hashimoto’s disease may use weight loss injections if they meet the other eligibility conditions and are evaluated by an endocrinologist. However, the type of thyroid disease, the medications used, thyroid hormone levels and family history must be reviewed.

Some weight loss medications containing semaglutide or tirzepatide should not be used in people with a personal or family history of medullary thyroid cancer or a diagnosis of Multiple Endocrine Neoplasia Type 2. Hypothyroidism, Hashimoto’s, simple goitre or every thyroid nodule are not the same as these conditions. Therefore, general conclusions such as “I have thyroid disease, so I can never use a weight loss injection” or “I take thyroid medication, so it is completely safe for me” should not be made.

This content is intended for general information. The suitability of a weight loss injection is determined not only according to thyroid disease but by evaluating body mass index, accompanying conditions, medications used, pregnancy plans and general health together.

Why Is the Type of Thyroid Disease Important?

Thyroid disease does not refer to a single diagnosis. Hypothyroidism, Hashimoto’s disease, hyperthyroidism, Graves’ disease, thyroid nodules, goitre and thyroid cancers have different causes, follow-up processes and treatments.

The thyroid warning in the official product information for weight loss injections is particularly associated with medullary thyroid cancer, which develops from the C cells of the thyroid, and MEN 2. This warning does not mean that every thyroid disease carries the same risk. Nevertheless, the person’s exact diagnosis must be known before treatment begins.

The following information is important during the evaluation:

• The exact name of the thyroid disease and when it was diagnosed
• The name and daily dose of the thyroid medication used
• The latest TSH and free T4 results
• Whether a nodule is present on thyroid ultrasound
• Whether a thyroid biopsy or surgery has previously been performed
• The type of thyroid cancer previously experienced
• A personal or family history of medullary thyroid cancer
• A personal or family diagnosis of MEN 2
• Whether a new neck mass, hoarseness or difficulty swallowing is present

Can a Person With Hypothyroidism Use Weight Loss Injections?

Hypothyroidism is a condition in which the thyroid gland cannot produce enough thyroid hormone to meet the body’s needs. Thyroid hormones affect many systems, including energy use, body temperature, bowel movements and heart rate. Hypothyroidism may be associated with fatigue, sensitivity to cold, constipation and weight gain.

Controlled hypothyroidism is not listed by itself as a contraindication in the official product information for medications containing semaglutide or tirzepatide. Therefore, some people whose TSH and free T4 values are within an appropriate range, who use levothyroxine regularly and who do not have a history of medullary thyroid cancer or MEN 2 may be evaluated for weight loss injections. The final decision should be made by an endocrinologist together with the person’s weight management needs and other health risks.

When hypothyroidism is not adequately controlled, thyroid treatment may need to be regulated first. This is because uncontrolled hypothyroidism may cause complaints such as weight gain, oedema, fatigue and slowed bowel movements. These symptoms may be confused with the digestive effects of weight loss injections and make it difficult to evaluate the treatment response.

Can People With Hashimoto’s Disease Use Weight Loss Injections?

Hashimoto’s disease is an autoimmune thyroid disease in which the immune system affects thyroid tissue. Over time, the disease may cause reduced thyroid hormone production and hypothyroidism. While some people with Hashimoto’s only undergo regular hormone monitoring, levothyroxine treatment may be used in those who develop hypothyroidism.

Hashimoto’s disease is not the same as medullary thyroid cancer or MEN 2. Therefore, the presence of Hashimoto’s alone does not constitute an official contraindication to weight loss injections containing semaglutide or tirzepatide. However, thyroid hormones should be controlled, the levothyroxine dose should be known and other autoimmune or metabolic conditions should be evaluated.

The following points may be reviewed before and during treatment in people with Hashimoto’s:

• TSH and free T4 levels
• Levothyroxine use pattern
• Thyroid size and any nodules
• Presence of insulin resistance or type 2 diabetes
• Digestive system conditions
• Rate of weight loss
• Changes in symptoms such as fatigue, palpitations, constipation and hair loss

As weight loss becomes significant or digestive complaints affect levothyroxine use, thyroid hormone levels may need to be checked again. The dose of thyroid medication should not be changed by the person solely on the basis of weight changes.

Can Weight Loss Injections Be Used With Hyperthyroidism or Graves’ Disease?

Hyperthyroidism is when the thyroid gland produces more thyroid hormone than necessary. Graves’ disease is a common autoimmune cause of hyperthyroidism. Hyperthyroidism may cause weight loss, a fast or irregular heartbeat, sweating, tremor, diarrhoea, muscle weakness and sleep problems.

In a person with active and uncontrolled hyperthyroidism, it is important to evaluate the thyroid disease before starting a weight loss injection. Existing weight loss may result from excess thyroid hormone rather than a healthy weight loss process. In addition, symptoms such as palpitations, digestive changes and weakness may be related both to thyroid disease and to other medications used.

After hyperthyroidism is controlled, heart rate is assessed and the person’s weight is reviewed again, whether weight loss treatment is needed can be determined. Starting a weight loss injection solely to lose weight rapidly before thyroid values are normalised may not be appropriate.

Can People With Thyroid Nodules Use Weight Loss Injections?

A thyroid nodule is a limited tissue change that forms within the thyroid gland. A significant proportion of nodules may be benign; however, the level of risk cannot be determined without evaluating the nodule’s structure, size, ultrasound characteristics and, when necessary, biopsy result.

The presence of a thyroid nodule alone is not listed as a definite contraindication for every weight loss injection. However, nodules identified during a physical examination or imaging should be appropriately evaluated before treatment. Current FDA product information also states that people with thyroid nodules should undergo further evaluation.

The following situations are particularly important in people with nodules:

• Rapid growth of the nodule
• New or increasingly noticeable swelling in the neck
• Persistent hoarseness
• Difficulty swallowing
• Unexplained shortness of breath
• Suspicious ultrasound findings
• An elevated calcitonin result that requires evaluation
• A family history of medullary thyroid cancer

If these symptoms are present, the nature of the thyroid nodule should be clarified before starting a weight loss injection. It is not safe to simply assume that the nodule is benign or to stop monitoring it during weight loss treatment.

Can People Who Have Had Thyroid Cancer Use Weight Loss Injections?

Thyroid cancers are not a single disease. Papillary, follicular, medullary and anaplastic thyroid cancers develop from different cells and are evaluated differently. The definite contraindication in the official product information for weight loss injections is particularly related to medullary thyroid cancer.

If the person or a first-degree family member has a history of medullary thyroid cancer, certain products containing semaglutide and tirzepatide should not be used. The same contraindication applies to people diagnosed with MEN 2. Although thyroid C-cell tumours were observed in animal studies, the meaning of this finding in humans has not been definitively established. Nevertheless, the official product information considers use contraindicated in these patient groups.

A previous history of papillary or follicular thyroid cancer is not listed in the same way as medullary thyroid cancer in the product information. However, this does not mean that the medication can be used safely without an evaluation. The type of cancer, whether treatment has been completed, whether the disease is active, the postoperative TSH target and the levothyroxine dose should be assessed together.

People who have previously had thyroid cancer should share the following information with their endocrinologist:

• The type of thyroid cancer stated in the pathology report
• History of surgery and radioactive iodine treatment
• Current disease follow-up status
• Thyroglobulin and relevant follow-up results
• TSH suppression target
• Current levothyroxine dose
• Family history of thyroid cancer or MEN 2

Can People Who Have Had Thyroid Surgery Use Weight Loss Injections?

Having part or all of the thyroid gland removed does not, by itself, provide sufficient information about weight loss injection use. The reason for surgery and the pathology result are decisive. Surgery may have been performed because of a benign nodule, goitre, Graves’ disease, papillary cancer or medullary thyroid cancer.

People who have undergone thyroid surgery for a benign condition and whose hormone levels are controlled with levothyroxine may be evaluated for weight loss injections if the other conditions are also appropriate. However, if the reason for surgery was medullary thyroid cancer, the relevant products containing semaglutide or tirzepatide should not be used.

As weight loss progresses in people using levothyroxine after thyroid surgery, hormone requirements may change. Therefore, monitoring TSH and, when necessary, free T4 throughout treatment helps assess whether the current dose is still appropriate.

What Does the Thyroid Warning on Weight Loss Injections Mean?

The boxed warnings for some medications containing semaglutide and tirzepatide mention thyroid C-cell tumours. This warning is based on the occurrence of C-cell tumours in rat studies in relation to the duration of exposure and dose.

It is not definitively known whether these medications cause medullary thyroid cancer in humans. Therefore, the warning does not mean that everyone who uses the medication will develop thyroid cancer. However, because of the potential risk, a personal or family history of medullary thyroid cancer and a diagnosis of MEN 2 must be assessed.

The official product information states that the value of routine calcitonin testing or regular thyroid ultrasound solely because a weight loss injection is being used is uncertain for the early detection of medullary thyroid cancer. In contrast, if there is a previously detected nodule, an elevated calcitonin result or a suspicious neck finding, an individual assessment should be performed.

Can Levothyroxine and Weight Loss Injections Be Used Together?

Levothyroxine is a thyroid hormone medication used to treat hormone deficiency caused by hypothyroidism and Hashimoto’s disease. There is no general rule stating that everyone who uses levothyroxine must avoid weight loss injections.

However, medications containing semaglutide and tirzepatide may delay stomach emptying and affect the absorption process of some oral medications. The FDA therefore recommends monitoring the effects of oral medications that require clinical or laboratory follow-up.

Taking levothyroxine regularly and correctly is important during treatment. If persistent vomiting, severe diarrhoea, a major change in eating patterns or significant weight loss develops after starting a weight loss injection, thyroid hormone levels may need to be reassessed.

The thyroid dose and hormone levels may be reviewed if the person experiences the following symptoms:

• New or worsening palpitations
• Excessive sweating and trembling
• Unexplained severe fatigue
• Significant constipation
• Increased sensitivity to cold or heat
• Sleep disturbance
• Faster-than-expected weight change
• A marked increase in hair loss

These symptoms may not be related only to the thyroid medication dose. Side effects of the weight loss injection, inadequate nutrition and other health problems may also cause similar complaints. Therefore, the levothyroxine dose should not be changed without testing.

Which Thyroid Tests May Be Evaluated Before a Weight Loss Injection?

TSH and free T4 are the blood tests most commonly used to assess thyroid function. When necessary, free T3, thyroid antibodies, calcitonin, ultrasound or fine-needle aspiration biopsy may also be used. However, not every test is required for every person; the choice of tests is determined according to the person’s diagnosis and clinical findings.

The following assessments may be performed before weight loss treatment in a person with known thyroid disease:

• Current TSH and free T4 results are reviewed.
• The thyroid medication use pattern is assessed.
• Existing nodule or ultrasound results are reviewed.
• If thyroid surgery has been performed, the pathology report is examined.
• A personal and family history of medullary thyroid cancer is assessed.
• A history of MEN 2 is investigated.
• Neck examination and current symptoms are evaluated.
• General eligibility conditions for weight loss treatment are reviewed.

Normal thyroid tests do not show that a weight loss injection is definitely suitable for the person. Similarly, a single abnormal TSH result does not mean that the person can never use these medications. The cause of the abnormality should first be determined and an individual plan should be created.

How Is Thyroid Follow-Up Performed During Treatment?

The frequency of follow-up is not the same for everyone. People whose thyroid hormones have been stable for a long time and whose levothyroxine dose has not changed may have different follow-up needs from those who have recently been diagnosed or whose hormone levels are not yet controlled.

The NIDDK states that the levothyroxine dose in hypothyroidism treatment should be adjusted according to blood tests and that the medication should not be stopped without speaking to a physician. Regular follow-up helps reduce problems that may result from excessively high or low hormone doses.

The following points may be included in the follow-up plan while using a weight loss injection:

• TSH and free T4 levels
• Rate of weight loss
• Levothyroxine use pattern
• Whether medication intake is affected by nausea, vomiting or diarrhoea
• Heart rate and palpitation complaints
• A new mass or swelling in the neck
• Changes involving the voice, swallowing and breathing
• Treatment adherence and side effects

The levothyroxine dose does not automatically need to be reduced as weight loss progresses. A dose change should only be made by evaluating laboratory results, symptoms and the person’s treatment targets together.

Which Thyroid Patients Should Not Use Weight Loss Injections?

According to the official information for the relevant products containing semaglutide or tirzepatide, the following people should not use these medications:

• People with a personal history of medullary thyroid cancer
• People with a first-degree family history of medullary thyroid cancer
• People diagnosed with Multiple Endocrine Neoplasia Type 2
• People with a serious allergy to the active ingredient or excipients of the medication

The decision is not automatic for other thyroid conditions. Further evaluation may be needed before starting a weight loss injection in people with uncontrolled hyperthyroidism, an unexplained thyroid nodule, a suspicious neck mass, active thyroid cancer follow-up or unstable thyroid hormones.

Which Symptoms Require Prompt Medical Evaluation?

People with thyroid disease who use weight loss injections should not ignore new changes in the neck area. These symptoms do not always mean cancer, but their cause should be determined.

Symptoms that require prompt evaluation include:

• A newly noticed mass or swelling in the neck
• Rapid growth of a previously known nodule
• Persistent or progressively worsening hoarseness
• Difficulty swallowing
• Unexplained shortness of breath
• A feeling of pressure in the neck
• New and persistent palpitations
• Fainting or chest pain

In the event of serious difficulty breathing, rapidly increasing throat swelling, chest pain or fainting, emergency healthcare should be contacted without waiting for an online consultation.

Plan Your Thyroid and Weight Management Process With an Online Endocrinologist Through Happ Health

For people with thyroid disease, the decision to use a weight loss injection should be based not only on weight but on a combined evaluation of the type of thyroid disease, hormone levels, medications used, nodule or surgery history and family history.

Through the Happ Health digital healthcare platform, you can reach an online endocrinologist and evaluate your thyroid tests, current treatment and weight management options with a specialist opinion. During the online consultation, whether medications containing semaglutide or tirzepatide are suitable for you, how levothyroxine monitoring should be planned and which checks may be necessary can be discussed according to your personal health information.

In the event of urgent symptoms such as rapidly growing neck swelling, serious shortness of breath, chest pain or fainting, the nearest healthcare facility should be contacted without waiting for an online consultation.

References

• U.S. Food and Drug Administration. Wegovy semaglutide current prescribing information.
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s005lbl.pdf
• U.S. Food and Drug Administration. Zepbound tirzepatide current prescribing information.
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
• National Institute of Diabetes and Digestive and Kidney Diseases. Hypothyroidism.
• https://www.niddk.nih.gov/health-information/endocrine-diseases/hypothyroidism
• National Institute of Diabetes and Digestive and Kidney Diseases. Hashimoto’s disease.
• https://www.niddk.nih.gov/health-information/endocrine-diseases/hashimotos-disease
• National Institute of Diabetes and Digestive and Kidney Diseases. Hyperthyroidism.
• https://www.niddk.nih.gov/health-information/endocrine-diseases/hyperthyroidism
• National Institute of Diabetes and Digestive and Kidney Diseases. Thyroid tests.
• https://www.niddk.nih.gov/health-information/diagnostic-tests/thyroid
• U.S. National Library of Medicine MedlinePlus. Semaglutide injection drug information.
• https://medlineplus.gov/druginfo/meds/a618008.html
• National Health Service. Levothyroxine.
• https://www.nhs.uk/medicines/levothyroxine/